Jennifer Larusso, DO
MOHS-Micrographic Surgery · Marlton, NJNPI 1932360906
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,067 of the $1,545 with a category attached, or 69.1%. 16 manufacturers reported payments, led by Johnson & Johnson at 39.1% of the total. Reporting peaked in 2020 at $461 and has fallen 96.6% since, to $16 in 2025.
Across 69 payments — averaging $22.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$604
- AbbVie$358
- Novartis$109
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$85
- Prugen, Inc. Pharmaceuticals$78
- Sanofi$58
- plus $253 from 10 others
What the payments were for
- Food & beverage$1,06769%
- Education$47831%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 16 | $604 |
| AbbVie | 25 | $358 |
| Novartis | 5 | $109 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $85 |
| Prugen, Inc. Pharmaceuticals | 1 | $78 |
| Sanofi | 2 | $58 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| Pfizer | 2 | $35 |
| LEO Pharma Inc. | 2 | $30 |
| Encore Dermatology Inc. | 2 | $27 |
| Sun Pharmaceutical Industries Inc. | 2 | $27 |
| UCB, Inc. | 1 | $19 |
| Smith+Nephew | 1 | $18 |
| Merz North America, Inc. | 1 | $16 |
| EPI Health, LLC | 1 | $15 |
| Journey Medical Corporation | 1 | $10 |
How this compares
$1,545 in reported general payments places this provider in the 60th percentile of 30 mohs-micrographic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 446 | $16,894 |
| Triamcinolone Acetonide | 145 | $2,595 |
| Fluorouracil | 25 | $1,658 |
| Betamethasone Dipropionate | 18 | $1,300 |
| Clindamycin Phosphate | 26 | $973 |
| Clobetasol Propionate | 18 | $904 |
| Ketoconazole | 53 | $856 |
| Mupirocin | 97 | $777 |
| Doxycycline Hyclate | 20 | $458 |
| Hydrocortisone | 71 | $400 |
| Econazole Nitrate | 12 | $338 |
| Nystatin | 11 | $215 |
| ErythromycinErythromycin Base | 16 | $162 |
| ValacyclovirValacyclovir Hcl | 17 | $135 |
| Clindamycin Hcl | 17 | $101 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Marlton
- David GoldbergHackensack$820K
- Marc GlashoferWest Orange$175K
- Kehua LiSewell$22K
- Steven WangBasking Ridge$11K
- John VinePrinceton$8K
- Lian Jie LiPhillipsburg$7K
- David NajarianRandolph$5K
- Parth PatelBridgewater$4K
- Shreya PatelWest Orange$3K
- Jeffrey WhitworthWoodland Park$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.